Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders

被引:265
作者
Howes, MJR
Perry, NSL
Houghton, PJ
机构
[1] Kings Coll London, Dept Pharm, London SE1 9NN, England
[2] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England
关键词
Alzheimer's disease; dementia; acetylcholinesterase inhibitors; antiinflammatories; antioxidants; nicotine; phytooestrogens; plants;
D O I
10.1002/ptr.1280
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In traditional practices of medicine, numerous plants have been used to treat cognitive disorders, including neurodegenerative diseases such as Alzheimer's disease (AD) and other memory related disorders. An ethnopharmacological approach has provided leads to identifying potential new drugs from plant sources, including those for memory disorders. There are numerous drugs available in Western medicine that have been directly isolated from plants, or are derived from templates of compounds from plant sources. For example, some alkaloids from plant sources have been investigated for their potential in AD therapy, and are now in clinical use (e.g. galantamine from Galanthus nivalis L. is used in the United Kingdom). Various other plant species have shown favourable effects in AD, or pharmacological activities indicating the potential for use in AD therapy. This article reviews some of the plants and their active constituents that have been used in traditional medicine, including Ayurvedic, Chinese, European and Japanese medicine, for their reputed cognitive-enhancing and antidementia effects. Plants and their constituents with pharmacological activities that may be relevant to the treatment of cognitive disorders, including enhancement of cholinergic function in the central nervous system, anti-cholinesterase (anti-ChE), antiinflammatory, antioxidant and oestrogenic effects, are discussed. Copyright (0 2003 John Wiley Sons, Ltd.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 327 条
[1]  
Abe K, 2000, PHYTOTHER RES, V14, P149, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt
[2]  
149::AID-PTR665&gt
[3]  
3.0.CO
[4]  
2-5
[5]  
AESBACH R, 1994, FOOD CHEM TOXICOL, V46, P1739
[6]   Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type [J].
Agid, Y ;
Dubois, B ;
Anand, R ;
Gharabawi, G .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (12) :837-845
[7]   NICOTINE-INDUCED PROTECTION OF CULTURED CORTICAL-NEURONS AGAINST N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED GLUTAMATE CYTOTOXICITY [J].
AKAIKE, A ;
TAMURA, Y ;
YOKOTA, T ;
SHIMOHAMA, S ;
KIMURA, J .
BRAIN RESEARCH, 1994, 644 (02) :181-187
[8]   MODIFICATION OF ARACHIDONIC METABOLISM BY FLAVONOIDS [J].
ALCARAZ, MJ ;
FERRANDIZ, ML .
JOURNAL OF ETHNOPHARMACOLOGY, 1987, 21 (03) :209-229
[9]  
ANBALAGAN K, 1985, International Journal of Crude Drug Research, V23, P177
[10]  
ANBALAGAN K, 1981, INDIAN J EXP BIOL, V19, P245